Global Orally Disintegrating Tablet Excipient Market Growth 2024-2031

Report ID: 1162462 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Orally Disintegrating Tablet Excipient by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Orally Disintegrating Tablet Excipient by Country/Region, 2017, 2022 & 2028
    2.2 Orally Disintegrating Tablet Excipient Segment by Type
        2.2.1 Binders
        2.2.2 Glidents
        2.2.3 Diluents
        2.2.4 Disintegrants
        2.2.5 Others
    2.3 Orally Disintegrating Tablet Excipient Sales by Type
        2.3.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2017-2022)
        2.3.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Type (2017-2022)
    2.4 Orally Disintegrating Tablet Excipient Segment by Application
        2.4.1 Anti-Psychotics Drug
        2.4.2 Anti-Epileptics Drug
        2.4.3 Others
    2.5 Orally Disintegrating Tablet Excipient Sales by Application
        2.5.1 Global Orally Disintegrating Tablet Excipient Sale Market Share by Application (2017-2022)
        2.5.2 Global Orally Disintegrating Tablet Excipient Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Orally Disintegrating Tablet Excipient Sale Price by Application (2017-2022)
3 Global Orally Disintegrating Tablet Excipient by Company
    3.1 Global Orally Disintegrating Tablet Excipient Breakdown Data by Company
        3.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Company (2020-2022)
        3.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2020-2022)
    3.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Company (2020-2022)
        3.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Company (2020-2022)
        3.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2020-2022)
    3.3 Global Orally Disintegrating Tablet Excipient Sale Price by Company
    3.4 Key Manufacturers Orally Disintegrating Tablet Excipient Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Orally Disintegrating Tablet Excipient Product Location Distribution
        3.4.2 Players Orally Disintegrating Tablet Excipient Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Orally Disintegrating Tablet Excipient by Geographic Region
    4.1 World Historic Orally Disintegrating Tablet Excipient Market Size by Geographic Region (2017-2022)
        4.1.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Geographic Region
    4.2 World Historic Orally Disintegrating Tablet Excipient Market Size by Country/Region (2017-2022)
        4.2.1 Global Orally Disintegrating Tablet Excipient Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Orally Disintegrating Tablet Excipient Annual Revenue by Country/Region
    4.3 Americas Orally Disintegrating Tablet Excipient Sales Growth
    4.4 APAC Orally Disintegrating Tablet Excipient Sales Growth
    4.5 Europe Orally Disintegrating Tablet Excipient Sales Growth
    4.6 Middle East & Africa Orally Disintegrating Tablet Excipient Sales Growth
5 Americas
    5.1 Americas Orally Disintegrating Tablet Excipient Sales by Country
        5.1.1 Americas Orally Disintegrating Tablet Excipient Sales by Country (2017-2022)
        5.1.2 Americas Orally Disintegrating Tablet Excipient Revenue by Country (2017-2022)
    5.2 Americas Orally Disintegrating Tablet Excipient Sales by Type
    5.3 Americas Orally Disintegrating Tablet Excipient Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Orally Disintegrating Tablet Excipient Sales by Region
        6.1.1 APAC Orally Disintegrating Tablet Excipient Sales by Region (2017-2022)
        6.1.2 APAC Orally Disintegrating Tablet Excipient Revenue by Region (2017-2022)
    6.2 APAC Orally Disintegrating Tablet Excipient Sales by Type
    6.3 APAC Orally Disintegrating Tablet Excipient Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Orally Disintegrating Tablet Excipient by Country
        7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2017-2022)
        7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2017-2022)
    7.2 Europe Orally Disintegrating Tablet Excipient Sales by Type
    7.3 Europe Orally Disintegrating Tablet Excipient Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Orally Disintegrating Tablet Excipient by Country
        8.1.1 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Country (2017-2022)
    8.2 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Type
    8.3 Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet Excipient
    10.3 Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
    10.4 Industry Chain Structure of Orally Disintegrating Tablet Excipient
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Orally Disintegrating Tablet Excipient Distributors
    11.3 Orally Disintegrating Tablet Excipient Customer
12 World Forecast Review for Orally Disintegrating Tablet Excipient by Geographic Region
    12.1 Global Orally Disintegrating Tablet Excipient Market Size Forecast by Region
        12.1.1 Global Orally Disintegrating Tablet Excipient Forecast by Region (2023-2028)
        12.1.2 Global Orally Disintegrating Tablet Excipient Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Orally Disintegrating Tablet Excipient Forecast by Type
    12.7 Global Orally Disintegrating Tablet Excipient Forecast by Application
13 Key Players Analysis
    13.1 BASF
        13.1.1 BASF Company Information
        13.1.2 BASF Orally Disintegrating Tablet Excipient Product Offered
        13.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 BASF Main Business Overview
        13.1.5 BASF Latest Developments
    13.2 JRS Pharma
        13.2.1 JRS Pharma Company Information
        13.2.2 JRS Pharma Orally Disintegrating Tablet Excipient Product Offered
        13.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 JRS Pharma Main Business Overview
        13.2.5 JRS Pharma Latest Developments
    13.3 Roquette
        13.3.1 Roquette Company Information
        13.3.2 Roquette Orally Disintegrating Tablet Excipient Product Offered
        13.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Roquette Main Business Overview
        13.3.5 Roquette Latest Developments
    13.4 ABF Ingredients
        13.4.1 ABF Ingredients Company Information
        13.4.2 ABF Ingredients Orally Disintegrating Tablet Excipient Product Offered
        13.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 ABF Ingredients Main Business Overview
        13.4.5 ABF Ingredients Latest Developments
    13.5 DFE Pharma
        13.5.1 DFE Pharma Company Information
        13.5.2 DFE Pharma Orally Disintegrating Tablet Excipient Product Offered
        13.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 DFE Pharma Main Business Overview
        13.5.5 DFE Pharma Latest Developments
    13.6 Evonik
        13.6.1 Evonik Company Information
        13.6.2 Evonik Orally Disintegrating Tablet Excipient Product Offered
        13.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Evonik Main Business Overview
        13.6.5 Evonik Latest Developments
    13.7 Merck KGaA
        13.7.1 Merck KGaA Company Information
        13.7.2 Merck KGaA Orally Disintegrating Tablet Excipient Product Offered
        13.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Merck KGaA Main Business Overview
        13.7.5 Merck KGaA Latest Developments
    13.8 Ashland
        13.8.1 Ashland Company Information
        13.8.2 Ashland Orally Disintegrating Tablet Excipient Product Offered
        13.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Ashland Main Business Overview
        13.8.5 Ashland Latest Developments
    13.9 Meggle Pharma
        13.9.1 Meggle Pharma Company Information
        13.9.2 Meggle Pharma Orally Disintegrating Tablet Excipient Product Offered
        13.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Meggle Pharma Main Business Overview
        13.9.5 Meggle Pharma Latest Developments
    13.10 Shin-Etsu
        13.10.1 Shin-Etsu Company Information
        13.10.2 Shin-Etsu Orally Disintegrating Tablet Excipient Product Offered
        13.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Shin-Etsu Main Business Overview
        13.10.5 Shin-Etsu Latest Developments
    13.11 Fuji Chemical Industries
        13.11.1 Fuji Chemical Industries Company Information
        13.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Offered
        13.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Fuji Chemical Industries Main Business Overview
        13.11.5 Fuji Chemical Industries Latest Developments
    13.12 McePharma (Vivesa holding)
        13.12.1 McePharma (Vivesa holding) Company Information
        13.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Offered
        13.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 McePharma (Vivesa holding) Main Business Overview
        13.12.5 McePharma (Vivesa holding) Latest Developments
    13.13 Cargill Incorporated
        13.13.1 Cargill Incorporated Company Information
        13.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Offered
        13.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Cargill Incorporated Main Business Overview
        13.13.5 Cargill Incorporated Latest Developments
    13.14 Daicel Corporation
        13.14.1 Daicel Corporation Company Information
        13.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Product Offered
        13.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Daicel Corporation Main Business Overview
        13.14.5 Daicel Corporation Latest Developments
    13.15 Anhui Sunhere Pharmaceutical
        13.15.1 Anhui Sunhere Pharmaceutical Company Information
        13.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Offered
        13.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Anhui Sunhere Pharmaceutical Main Business Overview
        13.15.5 Anhui Sunhere Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Orally Disintegrating Tablet Excipient Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Orally Disintegrating Tablet Excipient Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Binders
    Table 4. Major Players of Glidents
    Table 5. Major Players of Diluents
    Table 6. Major Players of Disintegrants
    Table 7. Major Players of Others
    Table 8. Global Orally Disintegrating Tablet Excipient Sales by Type (2017-2022) & (K MT)
    Table 9. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2017-2022)
    Table 10. Global Orally Disintegrating Tablet Excipient Revenue by Type (2017-2022) & ($ million)
    Table 11. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2017-2022)
    Table 12. Global Orally Disintegrating Tablet Excipient Sale Price by Type (2017-2022) & (USD/MT)
    Table 13. Global Orally Disintegrating Tablet Excipient Sales by Application (2017-2022) & (K MT)
    Table 14. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2017-2022)
    Table 15. Global Orally Disintegrating Tablet Excipient Revenue by Application (2017-2022)
    Table 16. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2017-2022)
    Table 17. Global Orally Disintegrating Tablet Excipient Sale Price by Application (2017-2022) & (USD/MT)
    Table 18. Global Orally Disintegrating Tablet Excipient Sales by Company (2020-2022) & (K MT)
    Table 19. Global Orally Disintegrating Tablet Excipient Sales Market Share by Company (2020-2022)
    Table 20. Global Orally Disintegrating Tablet Excipient Revenue by Company (2020-2022) ($ Millions)
    Table 21. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company (2020-2022)
    Table 22. Global Orally Disintegrating Tablet Excipient Sale Price by Company (2020-2022) & (USD/MT)
    Table 23. Key Manufacturers Orally Disintegrating Tablet Excipient Producing Area Distribution and Sales Area
    Table 24. Players Orally Disintegrating Tablet Excipient Products Offered
    Table 25. Orally Disintegrating Tablet Excipient Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 26. New Products and Potential Entrants
    Table 27. Mergers & Acquisitions, Expansion
    Table 28. Global Orally Disintegrating Tablet Excipient Sales by Geographic Region (2017-2022) & (K MT)
    Table 29. Global Orally Disintegrating Tablet Excipient Sales Market Share Geographic Region (2017-2022)
    Table 30. Global Orally Disintegrating Tablet Excipient Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 31. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Geographic Region (2017-2022)
    Table 32. Global Orally Disintegrating Tablet Excipient Sales by Country/Region (2017-2022) & (K MT)
    Table 33. Global Orally Disintegrating Tablet Excipient Sales Market Share by Country/Region (2017-2022)
    Table 34. Global Orally Disintegrating Tablet Excipient Revenue by Country/Region (2017-2022) & ($ millions)
    Table 35. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Country/Region (2017-2022)
    Table 36. Americas Orally Disintegrating Tablet Excipient Sales by Country (2017-2022) & (K MT)
    Table 37. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Country (2017-2022)
    Table 38. Americas Orally Disintegrating Tablet Excipient Revenue by Country (2017-2022) & ($ Millions)
    Table 39. Americas Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2017-2022)
    Table 40. Americas Orally Disintegrating Tablet Excipient Sales by Type (2017-2022) & (K MT)
    Table 41. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Type (2017-2022)
    Table 42. Americas Orally Disintegrating Tablet Excipient Sales by Application (2017-2022) & (K MT)
    Table 43. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Application (2017-2022)
    Table 44. APAC Orally Disintegrating Tablet Excipient Sales by Region (2017-2022) & (K MT)
    Table 45. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Region (2017-2022)
    Table 46. APAC Orally Disintegrating Tablet Excipient Revenue by Region (2017-2022) & ($ Millions)
    Table 47. APAC Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2017-2022)
    Table 48. APAC Orally Disintegrating Tablet Excipient Sales by Type (2017-2022) & (K MT)
    Table 49. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Type (2017-2022)
    Table 50. APAC Orally Disintegrating Tablet Excipient Sales by Application (2017-2022) & (K MT)
    Table 51. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Application (2017-2022)
    Table 52. Europe Orally Disintegrating Tablet Excipient Sales by Country (2017-2022) & (K MT)
    Table 53. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2017-2022)
    Table 54. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2017-2022) & ($ Millions)
    Table 55. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2017-2022)
    Table 56. Europe Orally Disintegrating Tablet Excipient Sales by Type (2017-2022) & (K MT)
    Table 57. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Type (2017-2022)
    Table 58. Europe Orally Disintegrating Tablet Excipient Sales by Application (2017-2022) & (K MT)
    Table 59. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Application (2017-2022)
    Table 60. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Country (2017-2022) & (K MT)
    Table 61. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue by Country (2017-2022) & ($ Millions)
    Table 63. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2017-2022)
    Table 64. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Type (2017-2022) & (K MT)
    Table 65. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Type (2017-2022)
    Table 66. Middle East & Africa Orally Disintegrating Tablet Excipient Sales by Application (2017-2022) & (K MT)
    Table 67. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Application (2017-2022)
    Table 68. Key Market Drivers & Growth Opportunities of Orally Disintegrating Tablet Excipient
    Table 69. Key Market Challenges & Risks of Orally Disintegrating Tablet Excipient
    Table 70. Key Industry Trends of Orally Disintegrating Tablet Excipient
    Table 71. Orally Disintegrating Tablet Excipient Raw Material
    Table 72. Key Suppliers of Raw Materials
    Table 73. Orally Disintegrating Tablet Excipient Distributors List
    Table 74. Orally Disintegrating Tablet Excipient Customer List
    Table 75. Global Orally Disintegrating Tablet Excipient Sales Forecast by Region (2023-2028) & (K MT)
    Table 76. Global Orally Disintegrating Tablet Excipient Sales Market Forecast by Region
    Table 77. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 78. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Americas Orally Disintegrating Tablet Excipient Sales Forecast by Country (2023-2028) & (K MT)
    Table 80. Americas Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 81. APAC Orally Disintegrating Tablet Excipient Sales Forecast by Region (2023-2028) & (K MT)
    Table 82. APAC Orally Disintegrating Tablet Excipient Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 83. Europe Orally Disintegrating Tablet Excipient Sales Forecast by Country (2023-2028) & (K MT)
    Table 84. Europe Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Forecast by Country (2023-2028) & (K MT)
    Table 86. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 87. Global Orally Disintegrating Tablet Excipient Sales Forecast by Type (2023-2028) & (K MT)
    Table 88. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 90. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Orally Disintegrating Tablet Excipient Sales Forecast by Application (2023-2028) & (K MT)
    Table 92. Global Orally Disintegrating Tablet Excipient Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Orally Disintegrating Tablet Excipient Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 94. Global Orally Disintegrating Tablet Excipient Revenue Market Share Forecast by Application (2023-2028)
    Table 95. BASF Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 96. BASF Orally Disintegrating Tablet Excipient Product Offered
    Table 97. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 98. BASF Main Business
    Table 99. BASF Latest Developments
    Table 100. JRS Pharma Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 101. JRS Pharma Orally Disintegrating Tablet Excipient Product Offered
    Table 102. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 103. JRS Pharma Main Business
    Table 104. JRS Pharma Latest Developments
    Table 105. Roquette Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 106. Roquette Orally Disintegrating Tablet Excipient Product Offered
    Table 107. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 108. Roquette Main Business
    Table 109. Roquette Latest Developments
    Table 110. ABF Ingredients Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 111. ABF Ingredients Orally Disintegrating Tablet Excipient Product Offered
    Table 112. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 113. ABF Ingredients Main Business
    Table 114. ABF Ingredients Latest Developments
    Table 115. DFE Pharma Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 116. DFE Pharma Orally Disintegrating Tablet Excipient Product Offered
    Table 117. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 118. DFE Pharma Main Business
    Table 119. DFE Pharma Latest Developments
    Table 120. Evonik Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 121. Evonik Orally Disintegrating Tablet Excipient Product Offered
    Table 122. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 123. Evonik Main Business
    Table 124. Evonik Latest Developments
    Table 125. Merck KGaA Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 126. Merck KGaA Orally Disintegrating Tablet Excipient Product Offered
    Table 127. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 128. Merck KGaA Main Business
    Table 129. Merck KGaA Latest Developments
    Table 130. Ashland Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 131. Ashland Orally Disintegrating Tablet Excipient Product Offered
    Table 132. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 133. Ashland Main Business
    Table 134. Ashland Latest Developments
    Table 135. Meggle Pharma Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 136. Meggle Pharma Orally Disintegrating Tablet Excipient Product Offered
    Table 137. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 138. Meggle Pharma Main Business
    Table 139. Meggle Pharma Latest Developments
    Table 140. Shin-Etsu Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 141. Shin-Etsu Orally Disintegrating Tablet Excipient Product Offered
    Table 142. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 143. Shin-Etsu Main Business
    Table 144. Shin-Etsu Latest Developments
    Table 145. Fuji Chemical Industries Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 146. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Offered
    Table 147. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 148. Fuji Chemical Industries Main Business
    Table 149. Fuji Chemical Industries Latest Developments
    Table 150. McePharma (Vivesa holding) Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 151. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Offered
    Table 152. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 153. McePharma (Vivesa holding) Main Business
    Table 154. McePharma (Vivesa holding) Latest Developments
    Table 155. Cargill Incorporated Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 156. Cargill Incorporated Orally Disintegrating Tablet Excipient Product Offered
    Table 157. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 158. Cargill Incorporated Main Business
    Table 159. Cargill Incorporated Latest Developments
    Table 160. Daicel Corporation Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 161. Daicel Corporation Orally Disintegrating Tablet Excipient Product Offered
    Table 162. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 163. Daicel Corporation Main Business
    Table 164. Daicel Corporation Latest Developments
    Table 165. Anhui Sunhere Pharmaceutical Basic Information, Orally Disintegrating Tablet Excipient Manufacturing Base, Sales Area and Its Competitors
    Table 166. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Offered
    Table 167. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
    Table 168. Anhui Sunhere Pharmaceutical Main Business
    Table 169. Anhui Sunhere Pharmaceutical Latest Developments
List of Figures
    Figure 1. Picture of Orally Disintegrating Tablet Excipient
    Figure 2. Orally Disintegrating Tablet Excipient Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Orally Disintegrating Tablet Excipient Sales Growth Rate 2017-2028 (K MT)
    Figure 7. Global Orally Disintegrating Tablet Excipient Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Orally Disintegrating Tablet Excipient Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Binders
    Figure 10. Product Picture of Glidents
    Figure 11. Product Picture of Diluents
    Figure 12. Product Picture of Disintegrants
    Figure 13. Product Picture of Others
    Figure 14. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type in 2021
    Figure 15. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2017-2022)
    Figure 16. Orally Disintegrating Tablet Excipient Consumed in Anti-Psychotics Drug
    Figure 17. Global Orally Disintegrating Tablet Excipient Market: Anti-Psychotics Drug (2017-2022) & (K MT)
    Figure 18. Orally Disintegrating Tablet Excipient Consumed in Anti-Epileptics Drug
    Figure 19. Global Orally Disintegrating Tablet Excipient Market: Anti-Epileptics Drug (2017-2022) & (K MT)
    Figure 20. Orally Disintegrating Tablet Excipient Consumed in Others
    Figure 21. Global Orally Disintegrating Tablet Excipient Market: Others (2017-2022) & (K MT)
    Figure 22. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2017-2022)
    Figure 23. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application in 2021
    Figure 24. Orally Disintegrating Tablet Excipient Revenue Market by Company in 2021 ($ Million)
    Figure 25. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Company in 2021
    Figure 26. Global Orally Disintegrating Tablet Excipient Sales Market Share by Geographic Region (2017-2022)
    Figure 27. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Geographic Region in 2021
    Figure 28. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2017-2022)
    Figure 29. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Country/Region in 2021
    Figure 30. Americas Orally Disintegrating Tablet Excipient Sales 2017-2022 (K MT)
    Figure 31. Americas Orally Disintegrating Tablet Excipient Revenue 2017-2022 ($ Millions)
    Figure 32. APAC Orally Disintegrating Tablet Excipient Sales 2017-2022 (K MT)
    Figure 33. APAC Orally Disintegrating Tablet Excipient Revenue 2017-2022 ($ Millions)
    Figure 34. Europe Orally Disintegrating Tablet Excipient Sales 2017-2022 (K MT)
    Figure 35. Europe Orally Disintegrating Tablet Excipient Revenue 2017-2022 ($ Millions)
    Figure 36. Middle East & Africa Orally Disintegrating Tablet Excipient Sales 2017-2022 (K MT)
    Figure 37. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue 2017-2022 ($ Millions)
    Figure 38. Americas Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2021
    Figure 39. Americas Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2021
    Figure 40. United States Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Canada Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Mexico Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Brazil Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 44. APAC Orally Disintegrating Tablet Excipient Sales Market Share by Region in 2021
    Figure 45. APAC Orally Disintegrating Tablet Excipient Revenue Market Share by Regions in 2021
    Figure 46. China Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Japan Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 48. South Korea Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Southeast Asia Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 50. India Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Australia Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2021
    Figure 53. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2021
    Figure 54. Germany Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 55. France Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 56. UK Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Italy Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Russia Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Middle East & Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country in 2021
    Figure 60. Middle East & Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country in 2021
    Figure 61. Egypt Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 62. South Africa Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Israel Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Turkey Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 65. GCC Country Orally Disintegrating Tablet Excipient Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Manufacturing Cost Structure Analysis of Orally Disintegrating Tablet Excipient in 2021
    Figure 67. Manufacturing Process Analysis of Orally Disintegrating Tablet Excipient
    Figure 68. Industry Chain Structure of Orally Disintegrating Tablet Excipient
    Figure 69. Channels of Distribution
    Figure 70. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Orally Disintegrating Tablet Excipient Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Orally Disintegrating Tablet Excipient Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Orally Disintegrating Tablet Excipient Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports